BridgeMD
Study of 18FET PET in functional pituitary adenomas with indeterminate MRI findings
EU CTIS ID: 2025-523829-17-00
What this study is testing
Estimate the positivity rate using 18FET PET in patients with de novo, recurrent, or persistent functional AP who are eligible for adenoma-targeted treatment (surgery and/or external beam radiation therapy) and have non-contributory pituitary MRI
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Male and/or female
- Aged 18 years or older
- Suspected functional pituitary adenoma (prolactinoma, Cushing's disease, acromegaly, thyrotropic adenoma), de novo or recurrence/persistence
- With indeterminate pituitary MRI
- Patient covered by social security
- Patient willing to comply with all study procedures and duration
You likely can't join if
- Pregnancy
- Known hypersensitivity to radiopharmaceuticals
- Administrative reasons: inability to receive informed consent, inability to participate in the entire study, lack of social security coverage, refusal to sign the consent form
- Patient with active alcohol consumption
- Patients suffering from liver disease or severe uncontrolled epilepsy
- Patients deprived of their liberty (guardianship, curatorship, etc.)
See the full eligibility criteria
- Male and/or female
- Aged 18 years or older
- Suspected functional pituitary adenoma (prolactinoma, Cushing's disease, acromegaly, thyrotropic adenoma), de novo or recurrence/persistence
- With indeterminate pituitary MRI
- Patient covered by social security
- Patient willing to comply with all study procedures and duration
- Patient eligible for surgery and/or radiotherapy in case of positive 18FET PET scan
- Pregnancy
- Known hypersensitivity to radiopharmaceuticals
- Administrative reasons: inability to receive informed consent, inability to participate in the entire study, lack of social security coverage, refusal to sign the consent form
- Patient with active alcohol consumption
- Patients suffering from liver disease or severe uncontrolled epilepsy
- Patients deprived of their liberty (guardianship, curatorship, etc.)
- Patients who do not speak French
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.